Overview

To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement

Status:
Recruiting
Trial end date:
2022-08-12
Target enrollment:
Participant gender:
Summary
The supplementation of hydrogen molecules as an aid, adjuvant, may speed up recovering the course of the disease. The purpose of this study is to determine the safety and possible efficacy of hydrogen supplements in different formula and dose exposures for a clinical study in rheumatologic patients. Patients will receive a different dosage of either hydrogen capsules, hydrogen gas or hydrogen-rich water with their conventional treatment for a month. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.
Phase:
Phase 1
Details
Lead Sponsor:
HoHo Biotech
Collaborator:
Tri-Service General Hospital